Albeit, these effects and the reported cholinesterase activity reduction [10,13,14], myopathy [3,5], and the current evidence considering the brain as a non-therapeutic (hypolipidemic) target for statins [28], could be related to neurobehavioral alterations reported in experimental animals [8,14,28]. Here, BCHE is linked to myopathy.